Literature DB >> 10620369

Purification and characterization of glutathione transferases from the sea bass (Dicentrarchus labrax) liver.

S Angelucci1, P Sacchetta, P Moio, S Melino, R Petruzzelli, P Gervasi, C Di Ilio.   

Abstract

Two forms of glutathione transferase were purified from liver cytosol of the sea bass (Dicentrarchus labrax) by GSH-Sepharose affinity chromatography followed by chromatofocusing. The major enzyme (DL-GST-6.7; 75% of total activity bound to the column) has a pI value of 6.7 and is composed of two subunits of apparent molecular mass 26.5 kDa. The minor enzyme (DL-GST-8.2; 25% of total activity bound to the column) has a pI value of 8.2 and is composed of two subunits of molecular mass 23.5 kDa. Both isoenzymes appear to have blocked N-terminal. The purified proteins were characterized with respect to substrate specificity, CD spectra, TNS binding properties (with 2-toluidinylnaphthalene 6-sulfonate), and immunological reactivity. Partial internal amino acid sequence was also determined for each isoenzyme. The results obtained suggest that DL-GST-6.7 and DL-GST8.2 are novel GSTs belonging, respectively, to theta and alpha classes. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10620369     DOI: 10.1006/abbi.1999.1569

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  9 in total

1.  Purification and properties of glutathione S-transferase from the pike liver.

Authors:  E V Borvinskaya; N N Nemova; L P Smirnov
Journal:  Dokl Biol Sci       Date:  2013-03-12

Review 2.  Recent advances in cancer immunotherapy.

Authors:  Qiang Sun; Gerry Melino; Ivano Amelio; Jingting Jiang; Ying Wang; Yufang Shi
Journal:  Discov Oncol       Date:  2021-08-18

Review 3.  Marine glutathione S-transferases.

Authors:  Brian Blanchette; Xia Feng; Bal Ram Singh
Journal:  Mar Biotechnol (NY)       Date:  2007-08-09       Impact factor: 3.619

Review 4.  Serine and one-carbon metabolisms bring new therapeutic venues in prostate cancer.

Authors:  Carlo Ganini; Ivano Amelio; Riccardo Bertolo; Eleonora Candi; Angela Cappello; Chiara Cipriani; Alessandro Mauriello; Carla Marani; Gerry Melino; Manuela Montanaro; Maria Emanuela Natale; Giuseppe Tisone; Yufang Shi; Ying Wang; Pierluigi Bove
Journal:  Discov Oncol       Date:  2021-10-27

5.  New immunological potential markers for triple negative breast cancer: IL18R1, CD53, TRIM, Jaw1, LTB, PTPRCAP.

Authors:  Paolo Marchetti; Alexey Antonov; Lucia Anemona; Chaitania Vangapandou; Manuela Montanaro; Andrea Botticelli; Alessandro Mauriello; Gerry Melino; M Valeria Catani
Journal:  Discov Oncol       Date:  2021-03-10

6.  Low level of plasminogen increases risk for mortality in COVID-19 patients.

Authors:  David Della-Morte; Francesca Pacifici; Camillo Ricordi; Renato Massoud; Valentina Rovella; Stefania Proietti; Mariannina Iozzo; Davide Lauro; Sergio Bernardini; Stefano Bonassi; Nicola Di Daniele
Journal:  Cell Death Dis       Date:  2021-08-05       Impact factor: 8.469

7.  NUAK2 and RCan2 participate in the p53 mutant pro-tumorigenic network.

Authors:  Eleonora Mammarella; Carlotta Zampieri; Emanuele Panatta; Gerry Melino; Ivano Amelio
Journal:  Biol Direct       Date:  2021-08-04       Impact factor: 4.540

8.  Understanding p53 tumour suppressor network.

Authors:  Emanuele Panatta; Carlotta Zampieri; Gerry Melino; Ivano Amelio
Journal:  Biol Direct       Date:  2021-08-06       Impact factor: 4.540

Review 9.  Global mapping of cancers: The Cancer Genome Atlas and beyond.

Authors:  Carlo Ganini; Ivano Amelio; Riccardo Bertolo; Pierluigi Bove; Oreste Claudio Buonomo; Eleonora Candi; Chiara Cipriani; Nicola Di Daniele; Hartmut Juhl; Alessandro Mauriello; Carla Marani; John Marshall; Sonia Melino; Paolo Marchetti; Manuela Montanaro; Maria Emanuela Natale; Flavia Novelli; Giampiero Palmieri; Mauro Piacentini; Erino Angelo Rendina; Mario Roselli; Giuseppe Sica; Manfredi Tesauro; Valentina Rovella; Giuseppe Tisone; Yufang Shi; Ying Wang; Gerry Melino
Journal:  Mol Oncol       Date:  2021-07-20       Impact factor: 6.603

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.